Study for Children with Myopia

Last updated: January 25, 2023
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

N/A

Condition

Myopia

Treatment

N/A

Clinical Study ID

TX310319
  • Ages 3-12
  • All Genders

Study Summary

The purpose of this study is to evaluate the efficacy of the study drug for the reduction of myopia progression in children.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Exclusion

Exclusion Criteria:

Study Design

Study Start date:
Estimated Completion Date:

Study Description

There is no cost to participate.

The child will use the study drug every day.

The child will have eye examination visits with an eye doctor twice a year for the next 4 years.

To learn more about this research study, please call us at: 919-346-6945

Connect with a study center

  • Oculus Research, Inc.

    Garner, North Carolina 27529
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.